Viewing Study NCT00633269


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT00633269
Status: COMPLETED
Last Update Posted: 2009-01-14
First Post: 2008-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04
Start Date Type: None
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2008-10
Completion Date Type: ACTUAL
First Submit Date: 2008-03-05
First Submit QC Date: None
Study First Post Date: 2008-03-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-01-13
Last Update Post Date: 2009-01-14
Last Update Post Date Type: ESTIMATED